Added Value of Contrast-enhanced US for Evaluation of Female Pelvic Disease.
Olinger K, Liu X, Khoshpouri P, Khoshpouri P, Scoutt L, Khurana A, Chaubal R, Moshiri M. Added Value of Contrast-enhanced US for Evaluation of Female Pelvic Disease. RadioGraphics 2024, 44: e230092. PMID: 38175802, DOI: 10.1148/rg.230092.Peer-Reviewed Original ResearchConceptsContrast-enhanced USFemale pelvisUS contrast agentEnd-stage renal diseaseContrast-enhanced CTExcellent safety profileModality of choiceUterine cavity morphologyVisualization of lesionsRenal diseaseGynecologic diseaseGynecologic tumorsPelvic diseaseSafety profileTubal patencyPelvic fistulasAdditional imagingIndeterminate lesionsContrast agentsDiseasePelvisImaging modalitiesExcellent optionLesionsCharacterization of disease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply